1. Home
  2. PFE vs ELV Comparison

PFE vs ELV Comparison

Compare PFE & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$24.08

Market Cap

147.6B

Sector

Health Care

ML Signal

HOLD

Logo Elevance Health Inc.

ELV

Elevance Health Inc.

HOLD

Current Price

$384.86

Market Cap

85.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFE
ELV
Founded
1849
1944
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.6B
85.7B
IPO Year
2013
2001

Fundamental Metrics

Financial Performance
Metric
PFE
ELV
Price
$24.08
$384.86
Analyst Decision
Buy
Buy
Analyst Count
14
19
Target Price
$29.29
$383.56
AVG Volume (30 Days)
29.6M
1.5M
Earning Date
05-05-2026
04-22-2026
Dividend Yield
6.55%
1.83%
EPS Growth
N/A
N/A
EPS
0.47
8.00
Revenue
$62,579,000,000.00
$199,125,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.07
P/E Ratio
$52.61
$49.39
Revenue Growth
N/A
12.49
52 Week Low
$23.11
$273.71
52 Week High
$28.75
$426.98

Technical Indicators

Market Signals
Indicator
PFE
ELV
Relative Strength Index (RSI) 27.62 44.37
Support Level $23.96 $307.76
Resistance Level $26.42 $408.00
Average True Range (ATR) 0.52 11.00
MACD -0.14 -3.91
Stochastic Oscillator 4.68 5.05

Price Performance

Historical Comparison
PFE
ELV

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

About ELV Elevance Health Inc.

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Share on Social Networks: